Hyperglycemia

This year is the first that I did not write a post on the weekend of the biannual daylight savings time change since the launch of this blog. In each earlier post, I aimed to raise awareness about health risks due to the time change.

Pregnant women with type 1 diabetes achieved a higher time in range and had fewer complications with use of a hybrid closed-loop insulin delivery system compared with continuous glucose monitoring alone, according to a speaker.

People with diabetes using a 15-day continuous glucose monitor sensor can now integrate their CGM with an automated insulin delivery system, according to a press release.

Breast Cancer Awareness Month is observed every October.

Patients with metastatic breast cancer treated with alpelisib as standard care had elevated blood glucose levels compared with those who received the drug as part of a clinical trial, according to data published in Cancer.

More than 80% of adults with diabetes using continuous glucose monitoring reported at least one instance of needing to stop using their device due to medical care or a device-related problem, according to survey findings.

The proportion of adults with diabetes in the U.S. achieving glycemic control was similar in 2013 to 2020 compared with 1988 to 1994, but racial-ethnic disparities worsened during that time, according to study data.

Use of continuous glucose monitoring was associated with improved glycemic control and a lower risk for hospitalization in adults with type 1 and type 2 diabetes attending Veterans Affairs clinics in the U.S., according to a speaker.

A study of women with menopause aged 45 to 60 years found that menopausal hormone therapy may reduce the odds of developing adhesive capsulitis.

The American Diabetes Association and the European Association for the Study of Diabetes released an updated consensus statement on the management of hyperglycemia among adults with type 2 diabetes.